Formulation factors for preparing ocular biodegradable delivery system of 5-fluorouracil microparticles

References

• AKBUGA, J., and BERGISADI, N., 1996, 5-Fluorouracil-loaded chitosan microspheres: preparation and release characteristics. Journal of Microencapsulation, 13, 161–168.
   PubMed Web of Science ®Google Scholar
• BOISDRON-CELLE, M., MENEI, P. H., and BENOIT, J. P., 1995, Preparation and characterization of 5-fluorouracil-loaded microparticles as biodegradable anticancer drug carriers. Journal of Pharmaceutics and Pharmacology, 47, 108–114.
   Google Scholar
• CHARLES, J. B., GANTHIER, R. J., WILSON, M. R., LEE, D. A., BAKER, R. S., LEONG, K. W., and GLASGOW, B. J., 1991, Use of bioerodible polymers impregnated with mitomycin in glaucoma filtration surgery in rabbits. Ophthalmology, 98, 503–508.
   PubMed Web of Science ®Google Scholar
• CIFTCI, K., HINCAL, A. A., KAS, H. S., ERCAN, T. M., SUNGUR, A., GUVEN, 0., and RUACAN, S., 1997, Solid tumor chemotherapy and in vivo distribution of fluorouracil following administration in poly(L-lactic acid) microspheres. Pharmaceutical Developments and Technology, 2, 151–160.
   Google Scholar
• Cirrci, K., KAS, H. S., HINCAL, A. A., ERCAN, T. M., GUVEN, 0., and RUACAN, S., 1996, In vitro and in vivo evaluation of PLAGA (50/50) microspheres containing 5-fluorouracil prepared by a solvent evaporation method. International Journal of Pharmaceutics, 131, 73–82.
   Google Scholar
• CoNI'', B., PAVANETTO, F., and GENTA, I., 1992, Use of polylactic acid for the preparation of microparticulate drug delivery systems. Journal of Microencapsulation, 9, 153–166. GOPFERICH, A., ALONSO, M. J., and LANGER, R., 1994, Development and characterization of microencapsulated microspheres. Pharmaceutical Research, 11, 1568–1580.
   Google Scholar
• GOULD, L., TROPE. G., CHENG, Y. L., HEATHCOTE, J. G., SHEARDOWN, H., ROOTMAN, D., Liu, G. S., and MENON, I. A., 1994, 50:50 poly(m.-glycolic acid-lactic acid) copolymer as a drug delivery system for 5-fluorouracil: a histopathological evaluation. Canadian Journal of Ophthalmology, 29, 168–171.
   Google Scholar
• HEUER, D. K., PARRISH, R. K., GRESSEL, M. G., HODAPP, E., DESJARDINS, D. C., SKUTA, G. L., PALMBERG, P. F., NEVAREZ, J. A., and ROCKWOOD, E. J., 1986, 5-Fluorouracil and glaucoma filtering surgery: III. Intermediate follow-up of a pilot study. Ophthalmology, 93, 1537–1546.
   Google Scholar
• HEUER, D. K., PARRISH, R. K., GRESSEL, M. G., HODAW, E., PALMBERG, P. F., and ANDERSON, D. R., 1984, 5-Fluorouracil and glaucoma filtering surgery: II. A pilot study. Ophthalmology, 91, 384–394.
   PubMed Web of Science ®Google Scholar
• JAMPEL, H. D., THIBAULT, D., LEONG, K. W., UPPAL, P., and QUIGLEY, H. A., 1993, Glaucoma filtration surgery in nonhuman primates using taxol and etoposide in polyanhydride carriers. Investigations in Ophthalmology and Vision Science, 34, 3076–3083.
   PubMed Web of Science ®Google Scholar
• JEYANTHI, R., and RAO, K. P., 1989, Release characteristics of bleomycin, mitomycin C and 5-fluorouracil from gelatin microspheres. International Journal of Pharmaceutics, 55, 31–37.
   Web of Science ®Google Scholar
• JONATHAN, H., 1992, Long-term results of trabeculectomy with collagen sponge implant containing low dose antirnetabolite. Ophthalmology, 99, 666–671.
   PubMed Web of Science ®Google Scholar
• KITAZAWA, Y., KAWASE, K., MATSUSHITA, H., and MINOBE, M., 1991, Trabeculectomy with mitomycin: a comparative study with fluorouracil. Archives of Ophthalmology, 109, 1693–1698.
   Google Scholar
• LATHA. M. S., JAYAKRISHNAN, A., RATHINAM, K., and MOHANTY, M., 1994. Casein as a carrier matrix for 5-fluorouracil: drug release from microspheres, drug-protein conjugates and in-vivo degradation of microspheres in rat muscle. Journal of Pharmaceutics and Pharmacology, 46, 858–862.
   Google Scholar
• MORA, J. S., NGUYEN, N., IwAmi, A. G., GANEY, M. M., HETHERINGTON, J., HOSKINS, H. D., WONG, P. C., TRAN, H., and DICKENS, C. J., 1996, Trabeculectomy with intraoperative sponge 5-fluorouracil. Ophthalmology, 103, 963–970.
   PubMed Web of Science ®Google Scholar
• OPHIR, A., and Timio, U., 1992, A randomized study of trabeculectomy and subconjunctival administration of fluorouracil in primary glaucomas. Archives of Ophthalmology, 110, 1072–1075.
   PubMedGoogle Scholar
• RABOWSKY, J. H., DUKES, A. J., LEE, D. A., and LEONG, K. W., 1996, The use of bioerodible polymers and daunorubicin in glaucoma filtration surgery. Ophthalmology, 103, 800–807.
   PubMed Web of Science ®Google Scholar
• ROCKWOOD, E. J., PARRISH, R. K., HEUER, D. K., SKUTA, G. L., HODAPP, E., PALMBERG, P. F., GRESSEL, M. G., and FEUER, W., 1987, Glaucoma filtering surgery with 5-fluorouracil. Ophthalmology, 94, 1071–1078.
   PubMed Web of Science ®Google Scholar
• SMITH, T. J., and AsirroN, P., 1996, Sustained-release subconjunctival 5-fluorouracil. Ophthalmic Surgery & Lasers, 27, 763–767.
   PubMedGoogle Scholar
• TILLEUL, P., DENTS, P., MAIGNEN, F., ELENA, P. P., NORDMANN, J. P., LEVERGE, R., and ROSTENE, W., 1997, Effects of different formulations of mitoxantrone (solutions, nanospheres, liposomes) on glaucoma surgery in rabbits. Ophthalmic Research, 29, 218–226.
   PubMed Web of Science ®Google Scholar
• TROPE, G. E., CHENG, Y. L., SHEARDOWN, H., Liu, G. S., MENON, I. A., HEATHCOTE, J. G., ROOTMAN, D. S., Cmou, W. J., and GOULD. L., 1994, Depot drug delivery system for 5-fluorouracil after filtration surgery in the rabbit. Canadian Journal of Ophthalmology, 29, 263–267.
   Google Scholar
• WAGNER, J. G., 1969, Interpretation of percent dissolved-time plots derived from in vitro testing of conventional tablets and capsules. Journal of Pharmaceutical Science, 58, 1253–1257.
   PubMed Web of Science ®Google Scholar
• WANG, G., TUCKER, I. G., ROBERTS, M. S., and HERsT, L. W., 1996, In vitro and in vivo evaluation in rabbits of a controlled release 5-fluorouracil subconjunctival implant based on poly(D,L-lactide-co-glycolide). Pharmaceutical Research, 13, 1059–1063.
   PubMed Web of Science ®Google Scholar
• YAMAMOTO, T., VARANI, J., SOONG, H. K., and LICHTER, P. R., 1990, Effects of 5-fluorouracil and mitomycin C on cultured rabbit subconjunctival fibroblasts. Ophthalmology, 97, 1204–1210.
   PubMed Web of Science ®Google Scholar
• YEH, M. K., COOMBES, A. G. A., JENKINS, P. G., and DAVIS, S. S., 1995a, A novel emulsification-solvent extraction technique for production of protein loaded biodegradable microparticles for vaccine and drug delivery. Journal of Controlled Release, 33, 437–445.
   Web of Science ®Google Scholar
• YEH, M. K., JENKINS, P. G., DAVIS, S. S., and COOMBES, A. G. A., 1995b, Improving the delivery capacity of microparticle systems using blends of poly(m.-lactide co-glycolide) and poly(ethylene glycol). Journal of Controlled Release, 37, 1–9.
   Web of Science ®Google Scholar
• ZIMMER, A., and KREUTER, J., 1995, Microspheres and nanoparticles used in ocular delivery systems. Advanced Drug Delivery Reviews, 16, 61–73.
   Web of Science ®Google Scholar